173 related articles for article (PubMed ID: 7508907)
21. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
22. Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets.
Vasir B; Reitz P; Xu G; Sharma A; Bonner-Weir S; Weir GC
Diabetologia; 2000 Jun; 43(6):763-72. PubMed ID: 10907122
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
Mandriota SJ; Pepper MS
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
[TBL] [Abstract][Full Text] [Related]
24. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.
Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS
Carcinogenesis; 2014 Aug; 35(8):1891-900. PubMed ID: 24876152
[TBL] [Abstract][Full Text] [Related]
25. A model system for tumor angiogenesis: involvement of transforming growth factor-alpha in tube formation of human microvascular endothelial cells induced by esophageal cancer cells.
Okamura K; Morimoto A; Hamanaka R; Ono M; Kohno K; Uchida Y; Kuwano M
Biochem Biophys Res Commun; 1992 Aug; 186(3):1471-9. PubMed ID: 1380804
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
[TBL] [Abstract][Full Text] [Related]
27. Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis.
Hu Z; Evarts RP; Fujio K; Omori N; Omori M; Marsden ER; Thorgeirsson SS
Carcinogenesis; 1996 May; 17(5):931-8. PubMed ID: 8640940
[TBL] [Abstract][Full Text] [Related]
28. Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium.
Koolwijk P; Kapiteijn K; Molenaar B; van Spronsen E; van der Vecht B; Helmerhorst FM; van Hinsbergh VW
J Clin Endocrinol Metab; 2001 Jul; 86(7):3359-67. PubMed ID: 11443212
[TBL] [Abstract][Full Text] [Related]
29. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
30. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
Colombo ES; Menicucci G; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tubular morphogenesis in human microvascular endothelial cells by co-culture with chondrocytes and involvement of transforming growth factor beta: a model for avascularity in human cartilage.
Tada K; Fukunaga T; Wakabayashi Y; Masumi S; Sato Y; Izumi H; Kohno K; Kuwano M
Biochim Biophys Acta; 1994 Nov; 1201(2):135-42. PubMed ID: 7947924
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
35. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line established from tsA58 large T transgenic mice.
Kanda S; Landgren E; Ljungström M; Claesson-Welsh L
Cell Growth Differ; 1996 Mar; 7(3):383-95. PubMed ID: 8838868
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis.
Sakurai H; Nigam SK
Am J Physiol; 1997 Jan; 272(1 Pt 2):F139-46. PubMed ID: 9039060
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor alpha mRNA in AsPC-1 human pancreatic cancer cells.
Ohba N; Funatomi H; Seki T; Makino R; Mitamura K
J Gastroenterol; 1999 Aug; 34(4):498-504. PubMed ID: 10452684
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
van Hinsbergh VW; van den Berg EA; Fiers W; Dooijewaard G
Blood; 1990 May; 75(10):1991-8. PubMed ID: 2140060
[TBL] [Abstract][Full Text] [Related]
40. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
